These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17052259)

  • 1. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
    Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
    Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.
    Bruckman KC; Schönleben F; Qiu W; Woo VL; Su GH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):632-7. PubMed ID: 20813562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.
    Cohen Y; Goldenberg-Cohen N; Shalmon B; Shani T; Oren S; Amariglio N; Dratviman-Storobinsky O; Shnaiderman-Shapiro A; Yahalom R; Kaplan I; Hirshberg A
    Oral Oncol; 2011 Oct; 47(10):946-50. PubMed ID: 21824802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population.
    Shah S; Shah S; Padh H; Kalia K
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):628-35. PubMed ID: 26453385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA is critical for the proliferation, invasiveness, and drug resistance of human tongue carcinoma cells.
    Chen Y; Hou Q; Yan W; Luo J; Chen D; Liu Z; He S; Ding X
    Oncol Res; 2011; 19(12):563-71. PubMed ID: 22812189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors.
    Wu G; Mambo E; Guo Z; Hu S; Huang X; Gollin SM; Trink B; Ladenson PW; Sidransky D; Xing M
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4688-93. PubMed ID: 15928251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIK3CA mutation status in Japanese esophageal squamous cell carcinoma.
    Mori R; Ishiguro H; Kimura M; Mitsui A; Sasaki H; Tomoda K; Mori Y; Ogawa R; Katada T; Kawano O; Harada K; Fujii Y; Kuwabara Y
    J Surg Res; 2008 Apr; 145(2):320-6. PubMed ID: 18262558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.
    Kostakis GC; Papadogeorgakis N; Koumaki V; Kamakari S; Koumaki D; Alexandridis C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):e53-8. PubMed ID: 20416519
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
    Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
    BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Shigaki H; Baba Y; Watanabe M; Murata A; Ishimoto T; Iwatsuki M; Iwagami S; Nosho K; Baba H
    Clin Cancer Res; 2013 May; 19(9):2451-9. PubMed ID: 23532889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA alterations in Middle Eastern ovarian cancers.
    Abubaker J; Bavi P; Al-Haqawi W; Jehan Z; Munkarah A; Uddin S; Al-Kuraya KS
    Mol Cancer; 2009 Jul; 8():51. PubMed ID: 19638206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
    Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours.
    Capodanno A; Boldrini L; Alì G; Pelliccioni S; Mussi A; Fontanini G
    Oncol Rep; 2012 Nov; 28(5):1559-66. PubMed ID: 22949056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, China.
    Wan X; Li X; Yang J; Lv W; Wang Q; Chen Y; Li Y
    Int J Clin Exp Pathol; 2015; 8(10):13360-6. PubMed ID: 26722541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.
    Gao L; Wang X; Wang X; Zhang L; Qiang C; Chang S; Ren W; Li S; Yang Y; Tong D; Chen C; Li Z; Song T; Zhi K; Huang C
    Oncotarget; 2014 May; 5(9):2562-74. PubMed ID: 24810113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.